Opiant Pharmaceuticals (OPNT) Tops Q3 EPS by 85c
Tweet
Share
E-mailGet Alerts OPNT Hot Sheet
Price: $20.65 --0%
Financial Fact:
Provision for income taxes: 2.28M
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Provision for income taxes: 2.28M
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Opiant Pharmaceuticals (NASDAQ: OPNT) reported Q3 EPS of $0.77, $0.85 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $16.3 million versus the consensus estimate of $10.21 million.
For earnings history and earnings-related data on Opiant Pharmaceuticals (OPNT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Etsy upgraded to buy at BofA on durable growth, buyback potential
- Walmart shares fall despite earnings beat
- Twin Disc (TWIN) Tops Q4 EPS by 16c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
